硕士于放射肿瘤科规培，积累了胸部肿瘤、消化道肿瘤等疾病的综合诊治经验。博士毕业于中山大学，致力于胸部肿瘤基础与临床研究。以第一作者/共同第一作者发表SCI论文2篇，累计影响因子10分。参与国家自然科学基金面上项目2项。参与ASCO Oral汇报2项。参与编写《肿瘤健康教育学》。【学术任职】广东省健康科普促进会肺癌分会委员。【主研方向】肿瘤转移进展及耐药机制研究。【获奖情况】【学术论著】1.Na Wang; Lie Zheng; Meichen Li; Xue Hou; Baishen Zhang; Jing Chen; Su Li; Likun Chen ;Clinical efficacy and safety of individualized pembrolizumab administration based on pharmacokinetic in advanced non-small cell lung cancer: a prospective exploratory clinical trial，Lung Cancer，2023，4(178):183-190. (期刊论文)，2. Weiquan Gu*; Na Wang*; Weiguang Gu; Yuan Qiu; Hua Zhang; Jianmiao Liang; Tongfei Zhou; Liheng Ma; Weijing Cai; Weineng Feng; Likun Chen ; Molecular gene mutation profiles，TMB and the impact of prognosis in Caucasians and east Asian patients with lung adenocarcinoma，Translational Lung Cancer Research，2020，9(3): 629-638. (期刊论文)，3. Meichen Li; Jing Chen; Baishen Zhang; Juan Yu; Na Wang; Delan Li; Yang Shao; Dongqin Zhu; Chuqiao Liang; Yutong Ma; Qiuxiang Ou; Xue Hou; Likun Chen ;Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)，BMC Medicine，2022，2(1): 398-410. (期刊论文)，4. Meichen Li; Xue Hou; Ke Sai; Lihong Wu; Jing Chen; Baishen Zhang; Na Wang; Lijia Wu; Hongbo Zheng; Jiao Zhang; Yonggao Mou; Likun Chen ; Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)，OncoImmunology，2022，11(1). (期刊论文)，5. Meichen Li; Xue Hou; Jing Chen; Baishen Zhang; Juan Yu; Na Wang; Delan Li; Yang Shao; Dongqin Zhu; Chuqiao Liang; Yutong Ma; Qiuxiang Ou; Likun Chen ; Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor response in non-small cell lung cancer patients with brain metastases: A prospective cohort study (GASTO 1028)，American Society of Clinical Oncology，chicago，2022-6-3至2022-6-7.(ASCO Oral会议报告)，6. Meichen Li; Delan Li; Xue Hou; Xiangheng Zhang; Na Wang; Jianzhong; Jing Chen; Kaicheng Wang; Likun Chen ; Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid，American Society of Clinical Oncology，chicago，2020-6-1至2020-6-1. (ASCO Oral会议报告)，7. Na Wang; Lie Zheng; Meichen Li; Xue Hou; Baishen Zhang; Jing Chen; Su Li; Likun Chen; Clinical efficacy and safety of individualized pembrolizumab administration based on pharmacokinetic in advanced non-small cell lung cancer: An open-label，single-arm，exploratory clinical trial，American Society of Clinical Oncology，chicago，2022-5-26. (ASCO Online会议报告).，8. 《肿瘤健康教育学》2018.08 ISBN号：978-7-5693-0431-2